Most Read Articles
Pearl Toh, 10 Jun 2020
COVID-19 patients appeared to be shedding virus to their surrounding the most during the first week of their illness, based on data from air and surface sampling of a hospital in Singapore.
6 days ago
A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Acute Kidney Injury in COVID-19: The need for early recognition

30 Jun 2020
We are currently dealing with an evolving global pandemic where new information can potentially change the course of the disease in the future. Featuring our leading expert in internal medicine and nephrology, Dr Alberto Chua, learn more about AKI as a complication of CoVid-19, and the role of biomarkers in the early diagnosis of AKI
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 10 Jun 2020
COVID-19 patients appeared to be shedding virus to their surrounding the most during the first week of their illness, based on data from air and surface sampling of a hospital in Singapore.
6 days ago
A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.